NASH initiation and progression is very complex.
Blocking multiple pathways will increase efficacy across a diverse population and disease pathogenisis.
Inhibits lipid synthesis by regulating the SREP1 pathway
Accelerates lipid oxidation/breakdown by binding PPAR-alpha which can modulate PPAR-gamma
Mitigates oxidative stress by having strong anti-oxidant activity
Web ViewMobile View